Armata Pharmaceuticals (ARMP) Assets (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Assets of $69.8 million for Q1 2026, down 9.21% sequentially from $76.9 million in Q4 2025, and down 20.0% YoY from $87.2 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Assets (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Assets for 14 years, with the latest figure at $69.8 million in Q1 2026.
- Quarterly Assets fell 20.0% year-over-year to $69.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.8 million (down 20.0% YoY) and the FY2025 annual result came in at $76.9 million, down 11.05% from the prior year.
- Assets retreated to $69.8 million in Q1 2026 per ARMP's latest filing, from $76.9 million in the prior quarter.
- Over five years, Assets peaked at $120.4 million in Q1 2024 and troughed at $69.8 million in Q1 2026.
- A 5-year average of $96.2 million and a median of $98.2 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets soared 117.67% in 2022, then dropped 27.51% in 2025.
- Over 5 years, Assets stood at $95.8 million in 2022, then rose by 2.64% to $98.4 million in 2023, then fell by 12.12% to $86.4 million in 2024, then fell by 11.05% to $76.9 million in 2025, then fell by 9.21% to $69.8 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $69.8 million, $76.9 million, and $89.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | 89.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.95 Mn |
| Mar 31, 2026 | 69.80 Mn |
| Dec 31, 2025 | 76.88 Mn |
| Sep 30, 2025 | 89.52 Mn |
| Jun 30, 2025 | 80.79 Mn |
| Mar 31, 2025 | 87.25 Mn |
| Dec 31, 2024 | 86.44 Mn |
| Sep 30, 2024 | 98.24 Mn |
| Jun 30, 2024 | 108.31 Mn |
| Mar 31, 2024 | 120.36 Mn |
| Dec 31, 2023 | 98.36 Mn |
| Sep 30, 2023 | 112.76 Mn |
| Jun 30, 2023 | 101.21 Mn |
| Mar 31, 2023 | 108.78 Mn |
| Dec 31, 2022 | 95.83 Mn |
| Sep 30, 2022 | 92.88 Mn |
| Jun 30, 2022 | 100.98 Mn |
| Mar 31, 2022 | 107.77 Mn |
| Dec 31, 2021 | 69.77 Mn |
| Sep 30, 2021 | 42.67 Mn |